Cryoport Systems’ Temperature-Controlled Supply Chain Blog
10/04/2024
Certify Safety for Human-derived Materials with Advanced Therapy Shippers®
The risk of contamination can compromise life-saving therapies, making it a major concern within the world of transporting precision medicines.
09/24/2024
Celebrating Our Recent Facility Expansion: A Recap of our Stevenage Global Supply Chain Hub Grand Opening Event
09/03/2024
Cryoshuttle® Service Brings Local Support to Stevenage, England
In June, Cryoport Systems officially launched our newest Global Supply Chain Hub in Stevenage, England, a renowned center for cell and gene therapy development within the U.K.
08/26/2024
3 Fundamental Services for Superior Master Cell Bank Management
The consistency of controlled conditions is vital throughout every step in producing advanced therapies, and the process usually begins with the secure handling and storage of the cells used for manufacturing.
07/22/2024
Weathering the Storm: Cryoport Systems’ Proactive Risk Mitigation During Hurricane Beryl
During the COVID-19 pandemic, the restrictions on transportation and travel negatively impacted patients' access to life-saving treatments and support.
07/16/2024
IntegriCell™: Extending Cell Viability with Manufacture-ready Cryopreserved Leukopaks
During the COVID-19 pandemic, the restrictions on transportation and travel negatively impacted patients' access to life-saving treatments and support.
06/27/2024
